Skip to main content
SpringerLink
Log in

Atrial Remodelling: What Have We Learned in the Last Decade?

  • Chapter
Cardiac Arrhythmias 2005

  • 658 Accesses

Conclusions

The progression of atrial fibrillation may be explained by the above-described effects of atrial remodelling. Maintaining sinus rhythms in atrial fibrillation by whatever means may slow the progression of remodelling and give patients benefit until safer antiarrhythmic drugs and ablation procedures are developed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allessie MA, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling in atrial fibrillation. Cardiovasc Res 54:230–246

    Article  PubMed  CAS  Google Scholar 

  2. Schotten U, Duytschaever M, Ausma J et al (2003) Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation 107:1433–1439

    Article  PubMed  Google Scholar 

  3. Wijffels MC, Kirchhof CJ, Dorland R et al (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954–1968

    PubMed  CAS  Google Scholar 

  4. Allessie MA, Konings KTS, Kirchhof CJHJ et al (1996) Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 77:10A–23A

    Article  PubMed  CAS  Google Scholar 

  5. Goette A, Honeycutt C, Langberg JJ (1996) Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 94:2968–2974

    PubMed  CAS  Google Scholar 

  6. Lai LP, Su MJ, Lin JL et al (1999) Down-regulation of L-type calcium channel land sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 33:1231–1237

    Article  PubMed  CAS  Google Scholar 

  7. Yu W-C, Chen S-A, Lee S-H et al (1998) Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs. Circulation 97:2331–2337

    PubMed  CAS  Google Scholar 

  8. Wijffels MC, Kirchhof CJ, Dorland R et al (1997) Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 96:3710–3720

    PubMed  CAS  Google Scholar 

  9. Daoud EG, Knight BP, Weiss R et al (1997) Effect of verpamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 95:1542–1550

    Google Scholar 

  10. Tieleman RG, Van Gelder IC, Crijns HJ et al (1998) Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 31:167–173

    Article  PubMed  CAS  Google Scholar 

  11. Tieleman RG, De Langen C, Van Gelder IC et al (1997) Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 95:1945–1953

    PubMed  CAS  Google Scholar 

  12. De Simone A, Stabile G, Vitale DF et al (1999) Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 34:810–814

    Article  PubMed  Google Scholar 

  13. Van Noord T, Tieleman RG, Bosker HA et al (2004) Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension. Europace 6:343–350

    Article  PubMed  Google Scholar 

  14. Dell’Orfano JT, Patel H, Wolbrette DL et al (1999) Acute treatment of atrial fibrillation: Spontaneous conversion rates and cost of care. Am J Cardiol 83:788–790

    Article  PubMed  CAS  Google Scholar 

  15. Dittrich HC, Ericson JS, Schneiderman T et al (1989) Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 63:193–197

    Article  PubMed  CAS  Google Scholar 

  16. Hobbs WJ, Van Gelder IC, Fitzpatrick AP et al (1999) The role of atrial electrical remodeling in the progression of focal atrial ectopy to persistent atrial fibrillation. J Cardiovasc Electrophysiol 10:866–870

    PubMed  CAS  Google Scholar 

  17. Allessie MA, Boyden PA, Camm AJ et al (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103:769–777

    PubMed  CAS  Google Scholar 

  18. Schotten U, Ausma J, Stellbrink C et al (2001) Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103:691–698

    PubMed  CAS  Google Scholar 

  19. San Fillippo AJ, Abascol VM, Sheehan M et al (1990) Atrial enlargement as a consequence of atrial fibrillation: A prospective echocardiographic study. Circulation 82:792–797

    Google Scholar 

  20. Manning WJ, Silverman DI, Katz SE et al (1994) Impaired left atrial mechanical function after cardioversion: relationship to the duration of atrial fibrillation. J Am Coll Cardiol 23:1535–1540

    Article  PubMed  CAS  Google Scholar 

  21. De Haan S, Blaauw Y, Van Hunnik A et al (2005) The novel Ito/IKur blocker AVE0118, but not the IKr blocker dofetilide, restores atrial contractility after cardioversion of atrial fibrillation in the goat. Heart Rhythm 2:S181 (abs)

    Google Scholar 

  22. Allessie MA, Boyden PA, Camm AJ et al (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103:769–777

    PubMed  CAS  Google Scholar 

  23. Solti F, Vecsey T, Kékesi V et al (1989) The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res 23:882–886

    Article  PubMed  CAS  Google Scholar 

  24. Ausma J, Wijffels M, Thone F et al (1997) Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96(9):3157–3163

    PubMed  CAS  Google Scholar 

  25. van der Velden HMW, van Kempen MJA, Wijffels MCEF et al (1998) Altered pattern of connexin-40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 9:596–607

    PubMed  Google Scholar 

  26. Kanagaratnam P, Cherian A, Stanbridge RDL et al (2004) Relationship between connexins and atrial activation during human atrial fibrillation. J Cardiovasc Electrophysiol 15:206–213

    Article  PubMed  Google Scholar 

  27. Li D, Fareh S, Leung TK et al (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100(1):87–95

    PubMed  CAS  Google Scholar 

  28. Nakashima H, Kumagai K, Urata H et al (2000) Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101(22):2612–2617

    PubMed  CAS  Google Scholar 

  29. Kumagai K, Nakashima H, Urata H et al (2003) Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 41(12):2197–2204

    Article  PubMed  CAS  Google Scholar 

  30. Pedersen OD, Bagger H, Kober L et al (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100(4):376–380

    PubMed  CAS  Google Scholar 

  31. Vermes E, Tardif JC, Bourassa MG et al (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 107:2926–2931

    Article  PubMed  Google Scholar 

  32. Madrid AH, Bueno MG, Rebollo JM et al (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 106:331–336

    Article  PubMed  CAS  Google Scholar 

  33. Murray KT, Rottman JN, Arbogast PG et al for the AFFIRM Investigators (2004) Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm 1: 669–675

    Article  PubMed  Google Scholar 

  34. Ross HM, Kowey PR, Naccarelli GV (2005) New antiarrhythmic pharmacologic therapies and regulatory issues in antiarrhythmic drug development. In: Wang P (ed) New Arrhythmia technologies. Oxford, Blackwell Publishing (in press)

    Google Scholar 

  35. Blaauw Y, Gogelein H, Tieleman RG et al (2004) ‘Early’ class III drugs for the treatment of atrial fibrillation. Efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation 110:1717–1724

    Article  PubMed  CAS  Google Scholar 

  36. Hsu LF, Jaïs P, Sanders P et al (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Penn State University College of Medicine, Hershey, PA, USA

    G. V. Naccarelli

  2. Maastricht University, Maastricht, The Netherlands

    M. A. Allessie

Authors
  1. G. V. Naccarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Allessie
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Divisione di Cardiologia, Ospedale Umberto I, Via Circonvallazione 50, I-30174, Venezia Mestre

    Antonio Raviele MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Naccarelli, G.V., Allessie, M.A. (2006). Atrial Remodelling: What Have We Learned in the Last Decade?. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_8

Download citation

  • DOI: https://doi.org/10.1007/88-470-0371-7_8

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0370-5

  • Online ISBN: 978-88-470-0371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation